Outlook Therapeutics launches $100M stock offering, discloses cash down to $7.7M
Filed May 13, 2026 · Period ending May 12, 2026 · ~1 min read
4 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade OTLK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 27, 2026 5:38 PM